France Greece Italy
The NANOMED EMJMD is a 23 month-long programme (120 ECTS) that is taught exclusively in English with a strong research component, including traineeships in the first and second years.
The NANOMED Consortium gathers 4 European Universities
- Université de Paris in France (Coordinator)
- Université d’Angers in France
- Università degli Studi di Pavia, Italy
- Panepistimio Patron, Greece
All members of the NANOMED Consortium have been working together hand in hand for several years to create a unique and comprehensive training which aims at teaching our students the latest evolutions in the field of Nanomedicine.
Given the present and future challenges of unmet medical needs and health issues in a European and global perspective, there is a huge expectation on innovative approaches such as Nanomedicine in the fields of therapy, diagnosis and theranostic (combination of therapy and diagnosis).
Europe must be a competitive arena for the development and successful implementation of new sustainable medicine/therapies based on nanosystems, contributing to a better life for Europe’s population and creating opportunities in the field of life sciences. One of the major needs is to develop new International curriculums at the MsC level as identified by the European Technology Platform for Nanomedicine (ETPN) in the report entitled “Education and Training Needs in Nanomedicine”. This report stresses out that there is an unmet need for an international training in the application of Nanomedicine to drug delivery within the currently existing European Master’s programmes.
The NANOMED EMJMD aiming at educating young scientists about the general principles of drug development and focuses more specifically on Drug Delivery Systems and Pharmaceutical Technology using both classical dosage forms and innovative delivery systems. It provides essential knowledge to go from basic training in Drug Delivery to advanced knowledge in Nanomedicine. Joining the NANOMED EMJMD is a great opportunity for future graduates to tackle Nanomedicine through multi-disciplinary perspectives and to learn about the latest advances in the field of Nanotechnology on the development of Advanced Particulate Drug Delivery Systems.
In addition, the NANOMED Consortium can profit from top-level facilities to deliver cutting-edge courses on characterization of nanoparticules (diffraction light scattering and electrophoretic mobility, DSC, FTIR, XRD, HPLC and UPLC – UV detection, mass spectroscopy, Raman Spectroscopy, interfacial rheology, etc.), their visualization by microscopy (Confocal Scanning, TEM, AFM, FRAP and SEM Microscopy Units) and their biological evaluation, both in vitro on cell cultures (complement activation, cytotoxicity assay, oral transport model, etc.) and in vivo on appropriate animal models (housing facilities, live animal imaging platforms, etc..).
What is Nanomedicine?
Nanomedicine is the application of Nanotechnology (materials with sizes in the nanometre range, i.e. 10-9 m) to promote innovation in Healthcare. Nanomedicine is a revolutionary interdisciplinary science, which combines knowledge from Pharmacy, Physics, Biology, Chemistry and Medicine to treat conditions and diseases of the human body at a molecular level. It has many applications, from drug therapy and diagnostics to individual cell repair, to artificial tissues and radiation therapy. The NANOMED EMJMD focuses on the Drug Delivery applications of Nanomedicine.
What is an EMJMD?
Erasmus Mundus Joint Master Degrees (EMJMDs) are highly integrated study programmes delivered by an international Consortium of Higher Education Institutions. They aim at fostering excellence, innovation, and internationalisation in Higher Education Institutions. EMJMDs are supported by the EACEA (Education, Audiovisual and Culture Executive Agency) of the European Commission and are part of the Erasmus + programme.
A key focus of EMJMDs is on encouraging mobility. The NANOMED curriculum is thus designed so that courses are held at different Partner Universities of the consortium, ensuring students spend time in at least two different countries of the consortium and has included two Traineeship periods as the research component of the degree.
It offers high quality education in the emerging field of Nanomedicine with a strong emphasis on multidisciplinarity. Designing nanomedicines for drug delivery requires the combination of knowledge from various fields such as Pharmacy, Biology, Chemistry, Medicine, Physics or Engineering, which is why our Master programme values students from different backgrounds. The NANOMED EMJMD provides both theoretical and practical knowledge for 3 semesters (Semesters 1, 2 and 3, 30 ECTS each) combined with a final internship (Semester 4, 30 ECTS).
Semester 1 Courses at Université de Paris OR University of Patras
Introduction to pharmaceutical formulation: from classical forms to nanoparticles.
Training will either take place in Patras or in Paris and will concern the Basis of Pharmaceutical Technology, i.e. Biopharmacy aspects, formulation, production as well as the related controls. This first step provides the essential knowledge necessary to work in Pharmaceutical domains and to introduce innovative drug delivery systems as used in Nanomedicine
An introductory biology or chemistry unit will be offered to non-pharmacy students with a background in chemistry or biology. Considering that some specific knowledge in both domains is required to efficiently design and develop pharmaceutical forms and in particular Nanomedicines, basic courses on biology will be provided to Chemists and chemistry courses to Biologists.
Semester 2 Courses at Université de Paris
Basic Nanomedicine and Biomolecules
The Basic Nanomedicine module covers the design of nanovectors for various administration routes as well as their subsequent characterization and evaluation (theoretical and practical courses). The first three months are dedicated to taught classes and the semester is completed by a three-month long traineeship carried out at one of the research teams within the Consortium network.
A two-week long Summer School is organized at the end of semester 2 (July) in one of the four partner universities of the NANOMED Consortium to give students the opportunity to benefit from high quality conferences of an Invited Professor. During the Summer School students will also be in charge of organizing and participating in a two-days-long Workshop. This Workshop will give NANOMED students from first and second year as well as local PhD students the opportunity to present their research projects (oral and poster communications will be organized).
Semester 3 Courses at Université d’Angers OR University of Pavia
Semester 3 will be dedicated to the Advanced Nanomedicine part of the curriculum. Students choose one of two specialization pathways and move to either the Université d’Angers, France or the University of Pavia, Italy depending on their route.
Strategy of Nanomedicine Development for Clinical Application
The Université d’Angers offers this specialization pathway focused on Clinical applications of Nanomedicine.
Production and Biotechnology applications of Nanomedicine
This curriculum, focusing on the biotechnological aspects, is offered by the University of Pavia
Semester 4 Traineeship at Partner University OR outside the Consortium
During the final internship period (6 months from January to June), students will apply this new knowledge to the successful achievement of research and development projects on Nanomedicine in either an academic team or selected private companies.
During the two-day-long workshop held in July, 2nd year students will defend their Master’s thesis in front of an international jury composed of external experts and NANOMED Professors.
EMJMD students should spend their Master’s Degree in at least two different countries. Consequently, students attending classes at Université de Paris during semester 1 and at Université d’Angers during semester 3 must go to a university outside of France during semester 2 or semester 4.
This mobility scheme, allows each student to access specific courses related to their personal interest or career plan and ensure both high quality training with various experts in Nanomedicine and development of professional soft skills through multicultural training. During the application process, students will be given the opportunity to disclose their preference regarding their destination for semester 3 but it is the Selection Committee that will make the final decision. This decision will essentially be based on each student’s background, experience and career plan. The students’ expressed preference will be fulfilled whenever possible.
To obtain the final diplomas (one from each Consortium member) and the diploma supplement, students must validate 4 semesters. The degrees will be delivered according to the decision of the Executive committee composed of at least one representative per Consortium member.
Opportunity is About:
Candidates should be from:
Description of Ideal Candidate:
- Completion of a Bachelor’s degree in Pharmacy, or (under special provisions) in Medicine, Chemistry, Biology, Biotechnology, Chemical Engineering, Biochemistry, Material Sciences or other adequate discipline. Graduate students having completed a five-year European curriculum in Pharmacy or Pharmaceutical Technology will also be eligible.
- Students in the final year of their Bachelor’s degree may also apply, provided that they will graduate no later than June 30th of the year preceding of their application. In this case, please upload an official letter stating the expected date of graduation.
The NANOMED EMJMD is an English-taught curriculum, thus English proficiency is a prerequisite to apply.
- For non-native speakers these are the English tests accepted to apply to the NANOMED EMJMD:
- IELTS (Academic) score > 6.5, with no less than 6.0 on each section
- TOEIC Speaking & Writing score Speaking > 160 and Writing > 150 and TOEIC Listening and Reading score score Listening at least 400 and Reading at least 350
- TOEFL iBT (internet-based test) score > 92, with no less than 21 on each section
- TOEFL CBT (computer-based test) score > 237, with no less than 21 on each section
- TOEFL PBT (paper-based test) score > 580, with no less than 55 on each section
- Cambridge Certificate of Proficiency in English (CPE) / Cambridge Certificate of Advanced English (CAE)
Tests scores provided should not be older than 2 years (except for Cambridge certificates).
- For native English speakers and non-native English speakers having completed their Bachelor’s degree in either United Kingdom, Ireland, Canada, USA, Australia or New Zealand are exempted from providing any English proficiency test certificate.
- For non-native speakers these are the English tests accepted to apply to the NANOMED EMJMD:
The selection will be based on different criteria listed in the following table with their respective weight. The most important criterion is the previous academic results along with the relevance between your background and the study of Nanomedicine. Previous practical experience such as work experience or traineeships in laboratories or private companies will also be greatly appreciated.
Deadline: January 15, 2022
Cost/funding for participants:
EMJMD scholarships include:
- Participation fees
- €1 000 per student/months covering life expenses for the whole duration of the NANOMED EMJMD (regardless of the country of origin)
IMPORTANT: the payment of the monthly allowance can only occur at the end of the first month of participation to the EMJMD so we kindly advise the students to anticipate their expenses on the first month of arrival (paying for security deposit, for the rent, for transportation)
Contribution to the travel and installation costs:
- €1 000 per academic year per scholarship holder resident in a Programme Country for travel costs
- €2 000 per academic year for travel costs + €1 000 for installation costs for a scholarship holder resident in a Partner Country located at less than 4 000 km from the student’s first destination within the NANOMED Consortium
- €3 000 per academic year for travel costs + €1 000 for installation costs for a scholarship holder resident in a Partner Country located at 4 000 km or more from the student’s first destination within the NANOMED Consortium
IMPORTANT: the payment of the travel and installation costs allocation can only occur at the end of the first month of participation to the EMJMD so we kindly advise the students to anticipate their expenses on the first month of arrival (paying for security deposit, for the rent, for transportation)
Health & travel insurance
International health and accident insurance complying with at least the minimum requirements for Erasmus Mundus Master Courses. Currently, the insurance provided to the student is the PROTRIP-WORLD-PLUS insurance of Dr. Walter’s insurance company.